Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Gut 2006;55:886-893; doi:10.1136/gut.2004.061663
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, M-Q
Right arrow Articles by Atherton, J C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, M-Q
Right arrow Articles by Atherton, J C
Topic Collections
Right arrowRelated Article

RECENT ADVANCES IN CLINICAL PRACTICE

Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management

M-Q Du1, J C Atherton2

1 Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
2 Wolfson Digestive Diseases Centre, University Hospital, Nottingham, UK

Correspondence to:
Correspondence to:
Professor J C Atherton
Wolfson Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH, UK; john.atherton@nottingham.ac.uk

Keywords: chromosomal translocation; Helicobacter pylori; mucosa associated lymphoid tissue; t(11;18)

The first 150 words of the full text of this article appear below.

Since mucosa associated lymphoid tissue (MALT) lymphomas were first recognised as a distinct entity in 1983, their characterisation and management have seen a series of rapid advances. Here we concentrate on MALT lymphomas at the commonest site—the stomach. Historically, despite their indolence, "localised" gastric low grade lymphomas were treated with surgery, and chemotherapy or radiotherapy were reserved for systemic spread. This emphasis has gradually changed but the major advance came with the discovery that these tumours were caused by Helicobacter pylori infection, and the remarkable finding that most resolved with its treatment.1H pylori eradication quickly became a firstline therapy, and the research focus changed to how best to assess which cases would respond to this. Endoscopic ultrasound became important for staging and, to some extent, stage predicted response to H pylori eradication. However, the most exciting research over the past eight years has been in understanding the molecular genetics . . . [Full text of this article]


Related Article

Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis
M Hummel, S Oeschger, T F E Barth, C Loddenkemper, S B Cogliatti, A Marx, H-H Wacker, A C Feller, H-W Bernd, M-L Hansmann, H Stein, and P Möller
Gut 2006 55: 782-787. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Nakamura, H. Ye, C. M. Bacon, A. Goatly, H. Liu, L. Kerr, A. H. Banham, B. Streubel, T. Yao, M. Tsuneyoshi, et al.
Translocations Involving the Immunoglobulin Heavy Chain Gene Locus Predict Better Survival in Gastric Diffuse Large B-Cell Lymphoma
Clin. Cancer Res., May 15, 2008; 14(10): 3002 - 3010.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S. Nakamura, H. Ye, C. M Bacon, H. Liu, A. Goatly, T. Matsumoto, H. Koga, J. Umeno, Y. Ohji, T. Yao, et al.
Gastric MALT lymphoma with t(14;18)(q32;q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication
J. Clin. Pathol., October 1, 2007; 60(10): 1171 - 1173.
[Full Text] [PDF]


Home page
GutHome page
S. Nakamura, H. Ye, C. M Bacon, A. Goatly, H. Liu, A. H Banham, R. Ventura, T. Matsumoto, M. Iida, Y. Ohji, et al.
Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation
Gut, October 1, 2007; 56(10): 1358 - 1363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology